Zoledronic Acid in Acute Spinal Cord Injury

Exclusion Criteria

• •Ventilator-dependent individuals
• •Chronic steroid use (defined as \>6 months)
• •Rheumatoid disease with use of prior disease modifying anti-rheumatic drugs (DMARDs) affecting bone density
• •History of osteoporosis or of treatment for osteopenia or osteoporosis with bisphosphonates, or selective reuptake estrogen modifying agents
• •History of more than one lower extremity osteoporosis-related fracture
• •Chronic renal insufficiency, creatinine clearance \< 35 ml/min, during screening
• •End stage liver or kidney disease
• •Medical conditions resulting in hypogonadal states that affect bone density
• •Uncontrolled thyroid disease/thyrotoxicosis
• •Hereditary or acquired metabolic bone disorder
• •History of use of unfractionated heparin for \>1 year
• •History of selected antiseizure medications, specifically phenobarbital, phenytoin, carbamazepine, sodium valproate \>1 year
• •Acute or chronic bilateral lower extremity fractures involving tibia or femur, with placement of surgical hardware in any areas of above locations
• •Severe hypotension requiring use of intravenous blood pressure agents such as dopamine, norepinephrine or phenylephrine. Exception may allow for patients on pressors who arm experiencing hypotension as they acclimate to upright posture.
• •Inability to provide informed consent and understand the consent process
• •Facial fractures requiring oral surgery
• •Dental surgery or oral maxillofacial surgery within 2 weeks of anticipated study drug administration
• •Pregnancy present on admission
• •Vitamin D deficiency on admission testing (serum 25-OH D reported as \< 13 ng/mL)
• •Patients with an established reaction to, or history of, anaphylactic shock to aspirin